Optimization of coronary sinus lead placement targeted to right-to-left delay in patients undergoing cardiac resynchronization therapy.
Aged
Aged, 80 and over
Arrhythmias, Cardiac
/ diagnosis
Cardiac Resynchronization Therapy
/ adverse effects
Cardiac Resynchronization Therapy Devices
Coronary Sinus
/ physiopathology
Disease Progression
Female
Heart Failure
/ diagnosis
Humans
Italy
Male
Middle Aged
Patient Admission
Prospective Studies
Recovery of Function
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Cardiac resynchronization therapy
Coronary sinus
Lead placement
Optimization
Pacing
Right to left delay
Journal
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649
Informations de publication
Date de publication:
01 Mar 2019
01 Mar 2019
Historique:
received:
23
06
2018
accepted:
18
10
2018
pubmed:
7
12
2018
medline:
22
9
2020
entrez:
4
12
2018
Statut:
ppublish
Résumé
Anatomical placement of the coronary sinus (CS) lead in basal or mid-ventricular positions of the posterior and lateral walls is associated with a better clinical outcome of cardiac resynchronization therapy (CRT). We hypothesized that optimization of CS lead placement targeted the right-to-left electrical delay (RLD) predicts an additional clinical benefit. The CS lead was placed according to current standards in 90 patients (Conventional group) and at the site of the longest RLD in 121 patients (RLD group). Non-responders were defined as those who died or underwent hospitalization for heart failure or did not improve in their Clinical Composite Score within 6 months. There were 67 (32%) non-responders. Compared with Conventional group, the final CS pacing site was more frequently in the basal segments in the RLD group (40% vs. 23%, P = 0.007); moreover, the RLD ratio (%RLD) of the total QRS width was longer (77 ± 13 vs. 73 ± 15, P = 0.05) and biventricular QRS shortened more from the baseline (-31 ± 21 ms vs. -21 ± 26 ms, P = 0.004). Nevertheless, the rate of non-responders was similar in the RLD and Conventional groups (35% vs. 28%, P = 0.30), as was %RLD (76 ± 16 vs. 75 ± 13, P = 0.66). QRS width during right ventricular (RV) pacing was an independent predictors of adverse outcome, with a 2% increase in the risk of failure for each 1 ms increase in QRS (P = 0.006). Optimization of CS lead placement targeted to latest electrical activation does not provide additional clinical benefit to anatomical placement in basal or mid-ventricular positions of the posterior and lateral walls. QRS width during RV pacing was a strong predictor of CRT failure. http://www.clinicaltrials.gov. Unique identifier: NCT03204864.
Identifiants
pubmed: 30508076
pii: 5224770
doi: 10.1093/europace/euy275
doi:
Banques de données
ClinicalTrials.gov
['NCT03204864']
Types de publication
Clinical Study
Comparative Study
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
502-510Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.